Literature DB >> 7310645

Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites.

K S Pang.   

Abstract

A model comprised of four compartments, a central and liver compartment for a drug, and a central and liver compartment for a metabolite, is presented to describe the interrelationships between the area under the curve of the metabolite and physiological parameters after intravenous and intraportal administration of the drug. The model includes renal and hepatic eliminatory mechanisms for both drug and metabolite as long as the metabolite is formed only by the liver. It is found that when competing renal eliminatory pathways exist for a drug, the area under the curve for the metabolite will change according to the route of drug administration. Also, the fractional rate of metabolism of a drug to form the metabolite will be underestimated by the normal use of the ratio areas under the curve of the metabolite. Other properties of the model are also discussed.

Mesh:

Substances:

Year:  1981        PMID: 7310645     DOI: 10.1007/bf01060890

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  12 in total

1.  Pharmacokinetics of carbamazepine-10,11- epoxide before and after autoinduction in rhesus monkeys.

Authors:  I H Patel; R H Levy; W F Trager
Journal:  J Pharmacol Exp Ther       Date:  1978-09       Impact factor: 4.030

2.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics.

Authors:  M Rowland; L Z Benet; S Riegelman
Journal:  J Pharm Sci       Date:  1970-03       Impact factor: 3.534

4.  Pharmacokinetic model for chlordiazepoxide--HCl in the dog.

Authors:  S A Kaplan; M Lewis; M A Schwartz; E Postma; S Cotler; C W Abruzzo; T L Lee; R E Weinfeld
Journal:  J Pharm Sci       Date:  1970-11       Impact factor: 3.534

5.  Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary.

Authors:  K S Pang; J R Gillette
Journal:  Drug Metab Dispos       Date:  1980 Jan-Feb       Impact factor: 3.922

6.  A method for the estimation of the fraction of a precursor that is converted to a metabolite in rat in vivo with phenacetin and acetaminophen.

Authors:  K S Pang; K Strobl; J R Gillette
Journal:  Drug Metab Dispos       Date:  1979 Nov-Dec       Impact factor: 3.922

7.  A theoretical examination of the effects of gut wall metabolism, hepatic elimination, and enterohepatic recycling on estimates of bioavailability and of hepatic blood flow.

Authors:  K S Pang; J R Gillette
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

8.  Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation.

Authors:  K S Pang; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

9.  Kinetic considerations relating to the accrual and elimination of drug metabolites.

Authors:  A J Cummings; B K Martin; G S Park
Journal:  Br J Pharmacol Chemother       Date:  1967-02

10.  Sequential first-pass elimination of a metabolite derived from a precursor.

Authors:  K S Pang; J R Gillette
Journal:  J Pharmacokinet Biopharm       Date:  1979-06
View more
  12 in total

1.  Absolute bioavailability of clarithromycin after oral administration in humans.

Authors:  S Y Chu; R Deaton; J Cavanaugh
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

2.  The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

Authors:  J P McGee; P N Shaw
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

3.  Primary, secondary, and tertiary metabolite kinetics.

Authors:  M V St-Pierre; X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

4.  Drug metabolite concentration-time profiles: influence of route of drug administration.

Authors:  J B Houston; G Taylor
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

5.  Drug metabolite kinetics: noncompartmental analysis.

Authors:  M Weiss
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

Review 6.  A review of metabolite kinetics.

Authors:  K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

7.  Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration.

Authors:  S H Akrawi; P J Wedlund
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

8.  Fractions metabolized in a triangular metabolic system: cinromide and two metabolites in the rhesus monkey.

Authors:  E A Lane; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

9.  A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.

Authors:  G R Weiss; T D Brown; J G Kuhn; D D Von Hoff; R H Earhart; W J Adams; J E Brewer; J D Hosley; D A Kasunic
Journal:  Invest New Drugs       Date:  1993-02       Impact factor: 3.850

10.  The kinetics of cyclosporine and its metabolites in bone marrow transplant patients.

Authors:  T L Schwinghammer; D Przepiorka; R Venkataramanan; C P Wang; G J Burckart; C S Rosenfeld; R K Shadduck
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.